Bank of America’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14M Buy
222,152
+110,400
+99% +$6.98M ﹤0.01% 2502
2025
Q1
$5.92M Buy
111,752
+7,264
+7% +$385K ﹤0.01% 3082
2024
Q4
$5.85M Sell
104,488
-1,762
-2% -$98.6K ﹤0.01% 2910
2024
Q3
$5.57M Buy
106,250
+14,207
+15% +$744K ﹤0.01% 3113
2024
Q2
$3.78M Sell
92,043
-19,071
-17% -$783K ﹤0.01% 3305
2024
Q1
$4.81M Buy
111,114
+41,244
+59% +$1.79M ﹤0.01% 3085
2023
Q4
$3.21M Sell
69,870
-40,373
-37% -$1.86M ﹤0.01% 3263
2023
Q3
$2.53M Sell
110,243
-29,875
-21% -$685K ﹤0.01% 3382
2023
Q2
$2.31M Sell
140,118
-219,548
-61% -$3.62M ﹤0.01% 3448
2023
Q1
$6.42M Buy
359,666
+93,513
+35% +$1.67M ﹤0.01% 2803
2022
Q4
$7.75M Buy
266,153
+47,744
+22% +$1.39M ﹤0.01% 2492
2022
Q3
$5.35M Buy
218,409
+169,297
+345% +$4.15M ﹤0.01% 2781
2022
Q2
$203K Buy
49,112
+9,497
+24% +$39.3K ﹤0.01% 5329
2022
Q1
$457K Sell
39,615
-83,020
-68% -$958K ﹤0.01% 5186
2021
Q4
$1.22M Sell
122,635
-81,828
-40% -$816K ﹤0.01% 4338
2021
Q3
$2.67M Buy
204,463
+84,785
+71% +$1.11M ﹤0.01% 3562
2021
Q2
$2.34M Buy
119,678
+13,236
+12% +$259K ﹤0.01% 3625
2021
Q1
$2.26M Buy
106,442
+16,283
+18% +$346K ﹤0.01% 3644
2020
Q4
$2.68M Sell
90,159
-188,221
-68% -$5.59M ﹤0.01% 3181
2020
Q3
$6.03M Buy
278,380
+22,222
+9% +$482K ﹤0.01% 2420
2020
Q2
$5.71M Buy
256,158
+209,649
+451% +$4.67M ﹤0.01% 2434
2020
Q1
$708K Sell
46,509
-3,551
-7% -$54.1K ﹤0.01% 3769
2019
Q4
$1.15M Buy
50,060
+14,604
+41% +$335K ﹤0.01% 3766
2019
Q3
$765K Buy
35,456
+8,823
+33% +$190K ﹤0.01% 4055
2019
Q2
$586K Buy
26,633
+6,871
+35% +$151K ﹤0.01% 4260
2019
Q1
$541K Sell
19,762
-6,434
-25% -$176K ﹤0.01% 4283
2018
Q4
$704K Buy
26,196
+14,085
+116% +$379K ﹤0.01% 4054
2018
Q3
$354K Buy
12,111
+5,860
+94% +$171K ﹤0.01% 4484
2018
Q2
$195K Buy
6,251
+3,282
+111% +$102K ﹤0.01% 4729
2018
Q1
$59K Sell
2,969
-733
-20% -$14.6K ﹤0.01% 5238
2017
Q4
$107K Buy
+3,702
New +$107K ﹤0.01% 4935